Weight Loss
Peptide-Based Metabolic Research
Research into peptide-based approaches to fat metabolism has identified compounds that may influence adipose tissue through distinct biological pathways. These include synthetic fragments of human growth hormone and targeted enzyme inhibitors that modulate cellular energy balance.
Studies suggest that peptides such as AOD 9604 and 5-Amino 1MQ interact with lipolytic and metabolic pathways, respectively, offering areas of investigation for researchers focused on body composition and metabolic regulation. AOD 9604 mimics the fat-reducing fragment of growth hormone without affecting IGF-1 or glucose metabolism, while 5-Amino 1MQ targets the NNMT enzyme to support NAD+ availability and mitochondrial efficiency.
All compounds are supplied strictly for laboratory research purposes. These statements have not been evaluated by the FDA.
Weight Loss Peptides
View All Weight Loss Products➝
How Peptides Support Weight Loss
Lipolytic Signaling
Research suggests AOD 9604 upregulates beta-3 adrenergic receptor expression in adipocytes, activating hormone-sensitive lipase via the cAMP/PKA cascade to promote triglyceride breakdown into free fatty acids.
Lipogenesis Inhibition
Studies indicate AOD 9604 may suppress acetyl-CoA carboxylase activity, reducing de novo fatty acid synthesis while promoting diacylglycerol release and protein kinase C activation.
NNMT Enzyme Inhibition
Research suggests 5-Amino 1MQ selectively inhibits nicotinamide N-methyltransferase, preventing nicotinamide methylation and redirecting precursors into the NAD+ salvage pathway to elevate intracellular NAD+ levels.
Metabolic Rate Enhancement
Elevated NAD+ from NNMT inhibition may support sirtuin-1 activation, enhancing mitochondrial function, basal metabolic rate, and fat oxidation capacity in preclinical models.
Research Protocols
Structured tiers for researchers investigating weight loss pathways, from foundational single-compound studies to multi-pathway protocols.
Beginner
Metabolic Reset
A foundational protocol for researchers beginning to explore peptide-based metabolic modulation across incretin, lipolytic, NNMT-inhibition, and mitochondrial support pathways.
Compounds
Intermediate
Metabolic Ignite
Combines lipolytic, incretin, GH-axis, mitochondrial, and metabolic-flexibility compounds for researchers investigating multi-pathway fat metabolism.
Advanced
Metabolic Apex
A comprehensive protocol for experienced researchers studying synergistic dual–GLP pathway signaling alongside lipolytic, GH-axis, NNMT inhibition, and metabolic flexibility compounds.
Explore the Weight Loss Collection
Browse all research-grade compounds for weight loss studies.
View Weight Loss ProductsThese statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. All products sold on this site are intended for laboratory research purposes only. Not for human consumption. MHS Longevity is a chemical supplier and is not a compounding pharmacy or outsourcing facility under 503A or 503B of the Federal Food, Drug, and Cosmetic Act.